SCHEMBL21787679

SCHEMBL21787679

CCCn1c(=O)c(O)cc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.48
CYP1A2 P05177 1/20 0.48
KMT2A Q03164 3/20 0.44
CYP19A1 P11511 1/20 0.44
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
MAPT P10636 4/20 0.42
MEN1 O00255 2/20 0.42
LMNA P02545 1/20 0.42
NOX4 Q9NPH5 2/20 0.42
CNR2 P34972 1/20 0.42
CCR2 P41597 1/20 0.41
SRC P12931 1/20 0.41
PRKACA P17612 1/20 0.41
PRKACG P22612 1/20 0.41
PRKACB P22694 1/20 0.41
GLS O94925 1/20 0.40
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21774723 0.89 CYP1A2 (0.57) CFTRCYP1A2KMT2ACYP19A1MAPT
SCHEMBL21774721 0.86 MAPT (0.50) CYP1A2CYP19A1MAPTNOX4CCR2
SCHEMBL17505196 0.82 CFTR (0.47) CFTRCYP1A2KMT2ACYP19A1ADORA2A
SCHEMBL20284504 0.82 CYP19A1 (0.56) CYP1A2KMT2ACYP19A1MAPTMEN1
SCHEMBL20548890 0.80 CYP1A2 (0.51) CFTRCYP1A2KMT2ACYP19A1MAPT
SCHEMBL21787628 0.80 PARG (0.43) CYP1A2CYP19A1MAPTNOX4CCR2
SCHEMBL6018883 0.79 CCR2 (0.61) CFTRCYP1A2KMT2ACYP19A1MAPT
SCHEMBL21787543 0.77 ADORA2A (0.43) CFTRCYP1A2KMT2AADORA2AADORA2B
SCHEMBL17505200 0.76 MAPT (0.51) CYP1A2KMT2AMAPTMEN1LMNA
SCHEMBL6173483 0.76 KMT2A (0.45) CFTRCYP1A2KMT2ACYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001570-B2 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-05-11 US disclosed
EP-3555063-B1 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2020-09-16 EP disclosed
US-20200071297-A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071297-A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BCL6, BCL6B, BCOR CFTR 827/4885CYP1A2 2925/4885KMT2A 216/4885
US-11001570-B2 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors BCL6, BCL6B, BCOR CFTR 866/4885CYP1A2 2466/4885KMT2A 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.